The Promotion and Marketing of OxyContin
Commercial Triumph, Public Health Tragedy
Datos Bibliográficos
| ID | 11027358 |
|---|---|
| Autores | Art Van Zee (autor de correspondencia) |
| Año | 2009 |
| Volumen | 99 |
| Número | 2 |
| Páginas | 221-227 |
| Fecha de publicación | 2009-02-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | American Journal of Public Health (JOURNAL) |
| Identificadores de la revista | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Editorial | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.2007.131714 |
| PMID | 18799767 |
| PMCID | PMC2622774 |
| OpenAlex | W2126791898 |
| Idioma | EN |
| Citas recibidas | 126 |
| Referencias citadas | 44 |
I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of controlled drugs by the pharmaceutical industry and an enhanced capacity of the Food and Drug Administration to regulate and monitor such promotion can have a positive impact on the public health
Business · Environmental health · Food and drug administration · Health promotion · Political science · Promotion (chess) · Public health · Public relations · Health Systems, Economic Evaluations, Quality of Life · Marketing · Medicine · Nursing · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare
Imaginaries of Writing and Pain
Is There a Prescription Drug Epidemic in Appalachian Kentucky?
Ethics, Public Health, and Addressing the Opioid Crisis
Shared Responsibility
Exploring opioid addictions and responsibilities
Interprofessional Learning Opportunity Regarding Pain and the Opioid Epidemic
Every ‘Never’ I Ever Said Came True”
Det syge USA
Moral cleansing as hypocrisy
White Health Benefits of Histories of Enslavement
Opioid use and stigma
Responding to the opioid crisis in North America and beyond
Elusive Travelers
Finding the Hidden Risk Profiles of the United States Opioid Epidemic
The Commercial Determinants of Violence
Opioid epidemics
Interdisciplinary approaches to the opioid crisis
Framing Appalachia
Pills and the damage done
Implementation of the Arizona Pain and Addiction Curriculum
The Opioid/Overdose Crisis as a Dialectics of Pain, Despair, and One-Sided Struggle
À l’heure d’un changement de paradigme de régulation des substances psychoactives
Exposure to Medicines in the Family Medicine Cabinet
Prescription Opioid Misuse
Framing and Policymaker Evaluations of the Opioid Crisis
Deflecting a “crisis”
Overdose prevention behaviors among people who inject drugs in rural Appalachia
‘We didn't cause the opioid epidemic’
Law enforcement capture of opioid settlement funding across Appalachia
The horror of corporate harms
Opium Price Shocks and Prescription Opioids in the USA
The effect of opioids on crime
Time series-based bibliometric analysis of a systematic review of multidisciplinary care for opioid dose reduction
Advocacy by nonprofit scientific institutions needs to be evidence-based
Geopolitical imagination and the US war on drugs against China
Dying for the Economy
Tool for Surveillance or Spotlight on Inequality? Big Data and the Law
Observations on 25 Years of Cannabis Law Reforms and Their Implications for the Psychedelic Renaissance in the United States
Optimal relief for pain at the end of life
False Hope and Fictitious Patents
Pockets of Weakness in Strong Institutions
The contributions of socioeconomic and opioid supply factors to U.S. drug mortality rates
Pains, guns and moves
Ending the Opioid Epidemic Requires a Historic Investment in Medication‐assisted Treatment
A Supply‐side Perspective on the Opioid Crisis
Contesting Deaths’ Despair
Reframing Addiction
Increases in BMI and chronic pain for US adults in midlife, 1992 to 2016
Avocados
Dynamics of combatting market-driven epidemics
Global burden and inequalities of drug use disorders from 1990 to 2021 with projections to 2036
Accountability in global health systems
Purdue's development of abuse-deterrent formulation opioids as a response to market competition
Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the Covid‐19 pandemic in Kentucky
Trends and Patterns of Opioid Analgesic Prescribing
Pharma-cology 101
How the Reformulation of OxyContin Ignited the Heroin Epidemic
Film Review
Testing hypotheses about the harm that capitalism causes to the mind and brain
How opioids became “safe”
White opioids
Reconceptualising the crimes of Big Tech
Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada
Stronger isn’t always better
Down in the valley
Prescription opioid misuse in the United States and the United Kingdom
Opioid Drought’, Canadian-style? Potential implications of the ‘natural experiment’ of delisting Oxycontin in Canada
Drug use behaviors, trauma, and emotional affect following the overdose of a social network member
OxyContin in Ontario
Interconnected influence
I have it just in case’ — Naloxone access and changes in opioid use behaviours
Categorising methadone
Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
Permissive regulation
The opioid crisis and the infrastructure of social capital
Restrictive opioid prescribing policies and evolving risk environments
A public health based vision for the management and regulation of opioids
Acid liberalism
The triple wave epidemic
Dynamics of drug overdose in the 20th and 21st centuries
Trends in accidental drug overdose mortality in Canada
Reformulation of oxycodone 80 mg to prevent misuse
The Opioid Crisis, Health, Healthcare, and Crime
This Is a Good Neighborhood. This Ain’t No Pittsburgh!”
Race as a Ghost Variable in (White) Opioid Research
The link between unemployment and opioid prescribing. An instrumental variable approach using evidence from England
Can Administrative Capacity Address Wicked Problems? Evidence From the Frontlines of the American Opioid Crisis
Marketing Cannabis Through Social Media
Drug Stigma, Consumer Culture, and Corporate Power in the Opioid Crisis
The Opioid Crisis and the Need for Compassion in Pain Management
Chronic Pain and Opioid Prescribing
Initiation of Heroin and Prescription Opioid Pain Relievers by Birth Cohort
A Comprehensive Approach to Address the Prescription Opioid Epidemic in Washington State
A History of Prescription Drug Monitoring Programs in the United States
Leading Causes of Unintentional and Intentional Injury Mortality
Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US–Mexico Border
Is the Prescription Opioid Epidemic a White Problem
Public Health Detailing—A Successful Strategy to Promote Judicious Opioid Analgesic Prescribing
Unemployment Insurance and Opioid Overdose Mortality in the United States
More immigrants, less death
| Obras citantes distintas | 126 |
|---|---|
| Citas por año | 8,4 |
| Intervalo de citas | 2011 - 2026 (16) |
| Velocidad de citación | current |
| Altamente citado | Sí |
| Tipos de cita | Neutras: 116 |